Management of Relapsed and Refractory Hodgkin Lymphoma in 2018

被引：2
|
作者：
Rutherford, Sarah C. [1 ]
Leonard, John P. [1 ]
机构：
[1] Weill Cornell Med, New York Presbyterian Hosp, Weill Dept Med, Meyer Canc Ctr,Div Hematol & Med Oncol, 1305 York Ave,7th Floor, New York, NY 10021 USA
来源：
JAMA ONCOLOGY | 2018年 / 4卷 / 08期
关键词：
STEM-CELL TRANSPLANTATION; BRENTUXIMAB VEDOTIN; PHASE-II; NIVOLUMAB; TRIAL; MULTICOHORT; THERAPY; FAILURE;
D O I：
10.1001/jamaoncol.2018.1767
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1120 / 1121
页数：2
相关论文
共 50 条
  • [21] PET/CT in the Evaluation of Relapsed or Refractory Hodgkin Lymphoma
    Jauhari, Shekeab
    Nasta, Sunita D.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (09) : 8 - 13
  • [22] Relapsed and refractory Hodgkin's lymphoma: New avenues?
    Canellos, George P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (05) : 929 - +
  • [23] How I treat relapsed and refractory Hodgkin lymphoma
    Kuruvilla, John
    Keating, Armand
    Crump, Michael
    BLOOD, 2011, 117 (16) : 4208 - 4217
  • [24] Allografting as salvage treatment in refractory/relapsed Hodgkin Lymphoma
    Giaccone, L.
    Brunello, L.
    Iovino, G.
    Festuccia, M.
    Dellacasa, C.
    Passera, R.
    Aydin, S.
    Busca, A.
    Bruno, B.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S501 - S501
  • [25] Pembrolizumab and allotransplants for relapsed refractory classical hodgkin lymphoma
    Halahleh, K.
    Muradi, I.
    Al-Rimawi, D.
    Ma'koseh, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 203 - 204
  • [26] Tumor associated macrophages in relapsed and refractory Hodgkin lymphoma
    Casulo, Carla
    Arcila, Maria
    Bohn, Olga L.
    Teruya-Feldstein, Julie
    Maragulia, Jocelyn
    Moskowitz, Craig H.
    LEUKEMIA RESEARCH, 2013, 37 (09) : 1178 - 1183
  • [27] NIVOLUMAB IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA: ARAGON EXPERIENCE
    Auria Caballero, C.
    Marco Betes, V
    De Poo Rodriguez, V
    Murillo Florez, I
    Lacalle Aicua, L.
    Dourdil Sahun, V
    Mayor Perez, L.
    Amarilla Lanzas, I
    Pimentel Feliciano, A.
    Rubio Escuin, R.
    Martinez Lazaro, B.
    Marco Amigot, J.
    Palomera Bernal, L.
    HAEMATOLOGICA, 2019, 104 : 461 - 461
  • [28] Novel therapeutic approaches in relapsed or refractory Hodgkin lymphoma
    Brockelmann, Paul J.
    von Tresckow, Bastian
    Engert, Andreas
    ONKOLOGIE, 2022, 28 (10): : 901 - 907
  • [29] A new option for relapsed or refractory Hodgkin's lymphoma
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2012, 13 (05): : E192 - E192
  • [30] Advances in the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
    Ramchandren, Radhakrishnan
    ONCOLOGIST, 2012, 17 (03): : 367 - 376
12345